{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:52:17Z","timestamp":1760575937676,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1053\/clon.2001.9246","type":"journal-article","created":{"date-parts":[[2003,10,28]],"date-time":"2003-10-28T15:41:36Z","timestamp":1067355696000},"page":"164-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Combined Results from Three Phase II Trials of Neoadjuvant Chemotherapy in Operable Adenocarcinoma of the Oesophagus"],"prefix":"10.1053","volume":"13","author":[{"given":"V.R","family":"Archer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.J","family":"Mulholland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.D","family":"Stocken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.J","family":"Darnton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.R","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/clon.2001.9246_RF1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jama.1991.03460100089030","article-title":"Rising incidence of adenocarcinoma of the oesophagus and gastric cardia","volume":"265","author":"Blot","year":"1991","journal-title":"JAMA"},{"key":"10.1053\/clon.2001.9246_RF2","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1001\/jama.1993.03510110056031","article-title":"Continuing climb in rates of esophageal adenocarcinoma: an update [letter]","volume":"270","author":"Blot","year":"1993","journal-title":"JAMA"},{"key":"10.1053\/clon.2001.9246_RF3","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1200\/JCO.1990.8.7.1231","article-title":"Evaluation of pre-and postoperative chemotherapy for resectable adenocarcinoma of the oesophagus or gastroesophageal junction","volume":"8","author":"Ajani","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1053\/clon.2001.9246_RF4","first-page":"474","article-title":"Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary","volume":"21","author":"Ajani","year":"1994","journal-title":"Semin Oncol"},{"key":"10.1053\/clon.2001.9246_RF5","doi-asserted-by":"crossref","first-page":"112S","DOI":"10.1378\/chest.113.1_Supplement.112S","article-title":"Current status of new drugs and multidisciplinary approaches in patients with carcinoma of the esophagus","volume":"113","author":"Ajani","year":"1998","journal-title":"Chest"},{"key":"10.1053\/clon.2001.9246_RF6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00000658-199409000-00012","article-title":"Radical lymph node dissection for cancer of the thoracic oesophagus","volume":"220","author":"Akiyama","year":"1994","journal-title":"Ann Surg"},{"key":"10.1053\/clon.2001.9246_RF7","first-page":"63","article-title":"Combined modality treatment of esophageal cancer","volume":"11","author":"Urba","year":"1997","journal-title":"Oncology"},{"key":"10.1053\/clon.2001.9246_RF8","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1200\/JCO.1993.11.6.1118","article-title":"Preoperative chemoirradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report","volume":"11","author":"Forastiere","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1053\/clon.2001.9246_RF9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1200\/JCO.1996.14.1.156","article-title":"Concurrent radiation therapy and chemotherapy followed by esophagectomy for localised esophageal carcinoma","volume":"14","author":"Bates","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1053\/clon.2001.9246_RF10","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJM199608153350702","article-title":"A comparison of multimodal therapy and surgery for esophageal adenocarcinoma","volume":"335","author":"Walsh","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/clon.2001.9246_RF11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0936-6555(98)80060-5","article-title":"A Phase II trial of cisplatin and 5-fluorouracil in adenocarcinoma of the oesophagus","volume":"10","author":"Steyn","year":"1998","journal-title":"Clin Oncol"},{"key":"10.1053\/clon.2001.9246_RF12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0936-6555(98)80032-0","article-title":"A Phase II trial of preoperative mitomycin, cisplatin and 5-fluorouracil in adenocarcinoma of the oesophagus","volume":"10","author":"Darnton","year":"1998","journal-title":"Clin Oncol"},{"key":"10.1053\/clon.2001.9246_RF13","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s002800050418","article-title":"Phase II Study of mitomycin, ifosfamide and cisplatin in adenocarcinoma of the oesophagus","volume":"37","author":"Allen","year":"1996","journal-title":"Cancer Chemother Pharmacol"},{"first-page":"51","year":"1997","series-title":"UICC TNM classification of malignant tumours","key":"10.1053\/clon.2001.9246_RF14"},{"key":"10.1053\/clon.2001.9246_RF15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimation from incomplete observation","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1053\/clon.2001.9246_RF16","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJM199812313392704","article-title":"Chemotherapy followed by surgery compared with surgery alone for localised esophageal cancer","volume":"339","author":"Kelsen","year":"1998","journal-title":"N Eng J Med"},{"key":"10.1053\/clon.2001.9246_RF17","series-title":"Oesophageal carcinoma","first-page":"37","author":"Roder","year":"1995"},{"key":"10.1053\/clon.2001.9246_RF18","first-page":"64","article-title":"Experience with cisplatin in treatment regimens for esophageal cancer","volume":"18","author":"Leichman","year":"1991","journal-title":"Semin Oncol"},{"key":"10.1053\/clon.2001.9246_RF19","first-page":"19","article-title":"Infusional 5\u2013FU: historical evolution, rationale and clinical experience","volume":"12","author":"Lockich","year":"1998","journal-title":"Oncology"},{"key":"10.1053\/clon.2001.9246_RF20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1200\/JCO.1993.11.1.22","article-title":"Intensive properative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction","volume":"11","author":"Ajani","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1053\/clon.2001.9246_RF21","first-page":"15","article-title":"Preoperative mitomycin, ifosfamide and cisplatin in squamous carcinoma of the oesophagus","volume":"80","author":"Ferry","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1053\/clon.2001.9246_RF22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1442-2050.1999.00037.x","article-title":"Two-field radical lymphadenectomy in the treatment of esophageal carcinoma","volume":"12","author":"Torres","year":"1999","journal-title":"Dis Esophagus"},{"key":"10.1053\/clon.2001.9246_RF23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0002-9610(98)00140-8","article-title":"The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer","volume":"176","author":"Law","year":"1998","journal-title":"Am J Surg"},{"key":"10.1053\/clon.2001.9246_RF24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0003-4975(99)01262-X","article-title":"What is the optimal distal resection margin for esophageal carcinoma?","volume":"69","author":"Casson","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/clon.2001.9246_RF25","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0022-5223(99)70377-6","article-title":"Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy","volume":"117","author":"Nigro","year":"1999","journal-title":"J Thoracic Cardiovasc Surg"},{"key":"10.1053\/clon.2001.9246_RF26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0016-5085(99)70175-7","article-title":"Micrometastases in esophagogastric cancer: high detection rate in resected rib segments","volume":"116","author":"O'Sullivan","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/clon.2001.9246_RF27","first-page":"1","article-title":"on behalf of the MRC Upper GI Tract Cancer Group. Medical Research Council, (MRC) randomised Phase III trial of surgery with or without preoperative chemotherapy in resectable cancer of the oesophagus [abstract]","volume":"83","author":"Clark","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1053\/clon.2001.9246_RF28","first-page":"S19","article-title":"A phase I dose finding study of a bi-weekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced esophageal cancer","volume":"24","author":"van der Gaast","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1053\/clon.2001.9246_RF29","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1200\/JCO.1999.17.10.3270","article-title":"Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer","volume":"17","author":"Ilson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/clon.2001.9246_RF30","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1200\/JCO.2000.18.4.868","article-title":"Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus","volume":"18","author":"Heath","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/clon.2001.9246_RF31","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/jcp.48.11.1064","article-title":"Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer","volume":"48","author":"Darnton","year":"1995","journal-title":"J Clin Pathol"},{"key":"10.1053\/clon.2001.9246_RF32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s004320050241","article-title":"Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and oesophageal carcinomas: a two colour flow-cytometric analysis","volume":"125","author":"Koyama","year":"1999","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1053\/clon.2001.9246_RF33","first-page":"388A","article-title":"ZD1839, an oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor: first phase I pharmacokinetic (PK) results in patients","volume":"18","author":"Hammond","year":"1999","journal-title":"Proc ASCO"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655501992465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655501992465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:21:27Z","timestamp":1760541687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655501992465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S0936655501992465"],"URL":"https:\/\/doi.org\/10.1053\/clon.2001.9246","relation":{},"ISSN":["0936-6555"],"issn-type":[{"type":"print","value":"0936-6555"}],"subject":[],"published":{"date-parts":[[2001,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined Results from Three Phase II Trials of Neoadjuvant Chemotherapy in Operable Adenocarcinoma of the Oesophagus","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/clon.2001.9246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}